Carrier Screening in Preconception Consultation in Primary Care

Overview

Journal J Community Genet

Publisher Springer

Specialty Health Services

Date 2011 Dec 21

PMID 22183783

Citations 21

Authors

Sylvia A Metcalfe

Affiliations

Soon will be listed here.

Abstract

Discussing carrier screening during preconception consultation in primary care has a number of advantages in terms of promoting autonomy and enabling the greatest range of reproductive choices. For those with a family history of an inherited condition, this ought to be a routine discussion; however, this can be expanded to include the wider population, especially for those conditions for which carrier frequencies are considered relatively common. There is published literature from around the world regarding experiences with carrier screening in primary care for cystic fibrosis, haemoglobinopathies, fragile X syndrome, Tay-Sachs disease and spinal muscular atrophy, although many of these have tended to focus on consultations during rather than before pregnancy. Overall, these studies reveal that population carrier screening is well received by the participants with apparent minimal psychosocial harms; however, challenges exist in terms of approaches to ensure couples receive adequate information to make personally relevant decisions and for ongoing health professional engagement.

Citing Articles

Understanding Genetic Screening: Harnessing Health Information to Prevent Disease Risks.

Lee C, Chuang C, Chiu H, Chang Y, Tu Y, Lo Y Int J Med Sci. 2025; 22(4):903-919.

PMID: 39991772 PMC: 11843151. DOI: 10.7150/ijms.101219.

Genetic study on candidates for oocyte donation.

Araujo S, Paula Neto A, Pinho M, Doria S, Barros A, Carvalho F JBRA Assist Reprod. 2024; 29(1):61-66.

PMID: 39688442 PMC: 11867239. DOI: 10.5935/1518-0557.20240087.

Primary care professionals' views on population-based expanded carrier screening: an online focus group study.

van den Heuvel L, Woudstra A, van der Hout S, Jans S, Wiersma T, Dondorp W Fam Pract. 2023; 41(4):571-578.

PMID: 36722294 PMC: 11324326. DOI: 10.1093/fampra/cmad011.

The more you do it, the easier it gets: using behaviour change theory to support health care professionals offering reproductive genetic carrier screening.

Best S, Long J, Fehlberg Z, Theodorou T, Hatem S, Archibald A Eur J Hum Genet. 2022; 31(4):430-444.

PMID: 36424524 PMC: 9686264. DOI: 10.1038/s41431-022-01224-5.

A Novel Compound Heterozygous Mutation in the DNAH11 Gene Found in Neonatal Twins With Primary Ciliary Dyskinesis.

Dong S, Bei F, Yu T, Sun L, Chen X, Yan H Front Genet. 2022; 13:814511.

PMID: 35295944 PMC: 8919259. DOI: 10.3389/fgene.2022.814511.

References

Su Y, Hung C, Lin S, Chen F, Chern J, Tsai C . Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study. PLoS One. 2011; 6(2):e17067. PMC: 3045421. DOI: 10.1371/journal.pone.0017067. View

Payne Y, Williams M, Cheadle J, STOTT N, Rowlands M, Shickle D . Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team. Clin Genet. 1997; 51(3):153-63. DOI: 10.1111/j.1399-0004.1997.tb02445.x. View

Kaback M . Screening and prevention in Tay-Sachs disease: origins, update, and impact. Adv Genet. 2001; 44:253-65. DOI: 10.1016/s0065-2660(01)44084-3. View

Metcalfe S, Jacques A, Archibald A, Burgess T, Collins V, Henry A . A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genet Med. 2008; 10(7):525-35. DOI: 10.1097/gim.0b013e31817c036e. View

Anido A, Carlson L, Sherman S . Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. J Genet Couns. 2007; 16(1):97-104. DOI: 10.1007/s10897-006-9049-0. View

Nolin S, Brown W, Glicksman A, Houck Jr G, Gargano A, Sullivan A . Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003; 72(2):454-64. PMC: 379237. DOI: 10.1086/367713. View

Ormond K, Iris M, Banuvar S, Minogue J, Annas G, Elias S . What do patients prefer: informed consent models for genetic carrier testing. J Genet Couns. 2007; 16(4):539-50. DOI: 10.1007/s10897-007-9094-3. View

Musci T . Screening for single gene genetic disease. Gynecol Obstet Invest. 2005; 60(1):19-26. DOI: 10.1159/000083481. View

Heredero-Baute L . Community-based program for the diagnosis and prevention of genetic disorders in Cuba. Twenty years of experience. Community Genet. 2004; 7(2-3):130-6. DOI: 10.1159/000080783. View

10.

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

11.

Palomaki G . Population based prenatal screening for the fragile X syndrome. J Med Screen. 1994; 1(1):65-72. DOI: 10.1177/096914139400100112. View

12.

Tambor E, Bernhardt B, Chase G, Faden R, Geller G, Hofman K . Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Hum Genet. 1994; 55(4):626-37. PMC: 1918300. View

13.

McClaren B, Delatycki M, Collins V, Metcalfe S, Aitken M . 'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening. Eur J Hum Genet. 2007; 16(4):435-44. DOI: 10.1038/sj.ejhg.5201965. View

14.

Watson E, Williamson R, Chapple J . Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public. Br J Gen Pract. 1991; 41(347):237-40. PMC: 1371586. View

15.

Henneman L, Bramsen I, VAN DER Ploeg H, Ader H, van der Horst H, Gille J . Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J Med Genet. 2001; 38(10):695-703. PMC: 1734747. DOI: 10.1136/jmg.38.10.695. View

16.

Metcalfe S, Hurworth R, Newstead J, Robins R . Needs assessment study of genetics education for general practitioners in Australia. Genet Med. 2002; 4(2):71-7. DOI: 10.1097/00125817-200203000-00004. View

17.

Cuckle H, Quirke P, Sehmi I, Lewis F, Murray J, Cross D . Antenatal screening for cystic fibrosis. Br J Obstet Gynaecol. 1996; 103(8):795-9. DOI: 10.1111/j.1471-0528.1996.tb09876.x. View

18.

Modell M . Screening for carriers of cystic fibrosis--a general practitioner's perspective. BMJ. 1993; 307(6908):849-52. PMC: 1678878. DOI: 10.1136/bmj.307.6908.849. View

19.

Al Arrayed S, Al Hajeri A . Public awareness of sickle cell disease in Bahrain. Ann Saudi Med. 2010; 30(4):284-8. PMC: 2931779. DOI: 10.4103/0256-4947.65256. View

20.

Muralidharan K, Wilson R, Ogino S, Nagan N, Curtis C, Schrijver I . Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology. J Mol Diagn. 2011; 13(1):3-6. PMC: 3069864. DOI: 10.1016/j.jmoldx.2010.11.012. View